Please assess the completion status of the following clinical trial:

Trial Title: Studies of Pandemic Influenza (H1N1) 2009 Vaccine in Bergen

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~Signed informed consent Subjects able to understand and comply with the study protocol and complete the Adverse Event Form Subjects able to attend the scheduled visits for the kinetic study~Exclusion Criteria:~* Persons with a history of anaphylaxis or serious reactions to any vaccine~* Person with known hypersensitivity to any of the vaccine components~* Persons who have had a temperature \>38oC during the previous 72 hours~* Persons who have had an acute respiratory infection during the last 7 days~* Suspected non-compliance

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- Pandemic influenza H1N1 vaccine (Type: EXPERIMENTAL): Influenza vaccine

Based on this trial design, predict the completion outcome and termination type (if applicable).